Lenoss Medical raises $4M financing for spine allograft

Lenoss Medical closed an oversubscribed series A funding round of $4 million to help accelerate commercialization of its OsteoPearl spinal allograft. 

Advertisement

The OsteoPearl biologic allograft is made from 100% cortical bone and is designed to stabilize vertebral compression fractures, according to a May 9 news release. The investment will also expand clinical evidence and support development.

Xcellerant Ventures, Highpoint Ventures, Vodia Capital, RightHill Ventures and other groups were involved with funding.

Advertisement

Next Up in Biologics

Advertisement